REGISTER NOW1

REGISTER NOW*

Start pump therapy now - with two months compatible CGM 

Happy New Year! 

As you may know the MiniMed 670G pump is now shipping in Australia. However, this is the pump only, as the Continuous Glucose Monitoring (CGM) that automates the system is currently under regulatory review. 

If you arrange your pump start before 26 January we will ensure 2019 is the year you can experience the full benefit of Medtronic’s next therapy as our New Year Program includes two months compatible CGM. If you choose, you can start pump therapy now and receive a complimentary CGM Protector Kit (Transmitter and two boxes of sensors) when a compatible sensor is available in Australia. 

This MiniMed 670G New Year Program is available to those aged seven and up, not available with any other offer previously signed up for. Pump start must be before 26 January 2019. You are able to start your two months of CGM before 25 April 2019.  

Invitation to the MiniMed 670G New Year Program

 1By providing information, you understand and agree that your personal information is being collected by Medtronic and entered into a database for the purpose of communicating offers and specials related to Medtronic products, services and technological advancements. We are collecting personal information and are required by law to notify you. Please read  our privacy collection statement and privacy policy statement ^Components are sold separately. † Waterproof at time of manufacture up to 3.6 metres for up to 24 hours at a time. See MiniMed ® 670G User Guide for a complete description of the waterproof capabilities and proper use instructions.

MINIMED 670G NEW YEAR PROGRAM 

1. The MiniMed 670G Insulin Pump (MM670G) is now included on the Australian Register of Therapeutic Goods. To ensure Medtronic Australasia Pty’s customers continue to have access to our newest technology available in Australia, for a limited time we have introduced the MM670G New Year Program, subject to the terms and conditions below.

2. An Eligible Customer for the MM670G New Year Program is an Australian resident who:

(a) has been diagnosed with Type 1 Diabetes;

(b) is over seven (7) years of age;

(c) has Private Health Insurance covering Insulin Pump Therapy or the ability to pay $9,025;

(d) is on Multiple Daily Injections or currently using an out of warranty Medtronic insulin pump or other insulin pump;

(e) has submitted a MiniMed 670G Order Form between 9 January 2019 and 25 January 2019 with a pump start date prior to 26 January 2019 in which an appropriate Health Care Professional has prescribed the MM670G; and

(f) Has not qualified for a past promotional offer such as the MiniMed 670G Access Program, Tech Upgrade CGM Subscription or a 3 months complimentary CGM in the past 12 months.

3. For each Eligible Customer, Medtronic will:

(a) supply the MM670G as ordered; and

(b) provide two months of Continuous Glucose Monitoring (CGM) (via CGM Protector Kit) at no further cost when the compatible CGM becomes available.

For the avoidance of doubt, the Eligible Customer can select to have the two months of CGM start when the compatible CGM is made available for the MM670G (which will be after delivery of the MM670G itself). The CGM start must be on or before 24 April 2019. The CGM will include up to one Transmitter and two boxes of Sensors (5 Sensors per box). Each Transmitter is valued at $699 and a box of Sensors is valued at $375.

4. StartRight: By participating in the MM670G New Year Program, Eligible Customers will be enrolled in our complimentary Personal Device Coaching Program ‘StartRight’. This is open to adults and guardians of children aged over seven (7) years. Eligible Customer’s may opt out of the StartRight Program at any time.

5. Delivery, Title & Risk:  The cost of transporting the MM670G and complimentary CGM (as applicable) under the MM670G New Year Program will be covered by Medtronic. Title and risk for the MM670G (when applicable) shall pass to the Eligible Customer on delivery at the Health Care Professional’s as nominated by the Eligible Customer. Title and risk for CGM shall pass to the Eligible Customer on delivery at the Eligible Customer nominated delivery address.

6. Warranty: The Warranty for the MM670G and CGM are provided in accordance with the terms of the Product Warranty which can be found at https://www.medtronic-diabetes.com.au/support/warranty.

Fix the following errors:
Hide